# US 2014/0234388 A1 · Bioscaffolds for formation of motor endplates and other specialized tissue structures

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0234388 A1
- Document ID: US20140234388A1
- Status: Published application
- Kind: A1
- Application number: 14/348,273
- Filed: 2012-09-28
- Published: 2014-08-21
- Earliest claimed: 2011-09-30
- Assignees: Wake Forest University Health Sciences
- Applicants: Wake Forest University Health Sciences
- Inventors: George J. Christ; Justin M. Saul; John B Scott; Benjamin T. Corona; Benjamin S. Harrison; Catherine Ward
- Web page: https://patentgrep.com/patent/US20140234388A1

## CPC

- A61L 27/227: {Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24}
- A61K 31/27: of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A61K 31/341: not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A61K 31/465: Nicotine; Derivatives thereof
- A61K 33/24: Heavy metals; Compounds thereof
- A61K 33/242: Gold; Compounds thereof
- A61K 33/26: Iron; Compounds thereof
- A61K 33/38: Silver; Compounds thereof
- A61L 27/3604: {characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel}
- A61L 27/3826: {Muscle cells, e.g. smooth muscle cells}
- A61L 27/3873: {Muscle tissue, e.g. sphincter}
- A61L 27/446: {with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46}
- A61L 27/48: with macromolecular fillers
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/58: Materials at least partially resorbable by the body
- C12N 5/0658: {Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts}
- G01N 33/553: Metal or metal coated
- A61K 38/17: from animals; from humans {(enzyme inhibitors A61K38/005)}
- A61L 2300/252: Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L 2300/622: Microcapsules
- A61L 2430/30: for muscle reconstruction
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Provided herein are scaffolds and methods useful to promote the formation of functional clusters on a tissue, for example, motor endplates (MEPs) or a component thereof on skeletal muscle cells or tissue, as well as the use of scaffolds so produced for repairing a tissue injury or defect.

## Claims

### Claim 1

A scaffold comprising beads therein or thereon, wherein said beads comprise an agent of interest.

### Claim 2 (depends on 1)

The scaffold of claim 1, wherein said agent of interest is incorporated onto said beads though covalent coupling.

### Claim 3 (depends on 1)

The scaffold of claim 1, wherein said beads are provided in or on said scaffold at a density of 103 to 2×1010 beads per cubic centimeter of scaffold volume.

### Claim 4 (depends on 1)

The scaffold of claim 1, wherein said beads comprises polystyrene, poly(ethylene), poly(lactic acid), poly(glycolic acid), or poly(lactic-co-glycol acid).

### Claim 5 (depends on 1)

The scaffold of any of claim 1, wherein said beads comprise gold, silver, or iron oxide.

### Claim 6 (depends on 1)

The scaffold of any of claim 1, wherein said scaffold is a skeletal muscle cell scaffold or a cardiac muscle cell scaffold.

### Claim 7 (depends on 1)

The scaffold of any of claim 1, wherein said agent of interest is agrin.

### Claim 8 (depends on 1)

The scaffold of any of claim 1, wherein said beads are microbeads.

### Claim 9 (depends on 1)

The scaffold of any of claim 1, wherein said scaffold comprises fibrin, collagen, agarose, cellulose, alginate, agarose, keratin, hydroxymethyl cellulose, or poly(hydroxyethylmethacrylate).

### Claim 10 (depends on 1)

A method of making a skeletal muscle implant comprising:
providing a scaffold according claim 1; and
seeding muscle cells onto said scaffold.

### Claim 11 (depends on 10)

The method of claim 10, wherein said muscle cells are myoblast cells or satellite cells.

### Claim 12 (depends on 10)

The method of claim 10, further comprising the step of isolating muscle cells from a donor tissue.

### Claim 13

A method of making a scaffold comprising beads therein or thereon, comprising:
providing a hydrogel comprising beads, said beads comprising an agent of interest;
applying said hydrogel onto a fiber template;
polymerizing said hydrogel around said fiber template to form a polymerized hydrogel; and then,
selectively dissolving said fiber template to create hollow tubes within said polymerized hydrogel, to thereby make the scaffold comprising beads therein or thereon.

### Claim 14 (depends on 13)

The scaffold of claim 13, wherein said hydrogel comprises fibrin, collagen, agarose, cellulose, alginate, agarose, keratin, hydroxymethyl cellulose, or poly(hydroxyethylmethacrylate).

### Claim 15 (depends on 13)

The scaffold of claim 13, wherein said fiber template comprises polystyrene, poly(ethylene glycol), poly(tetrafluoroethylene) poly(vinyl alcohol), poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic acid), poly(caprolactone), or alginate.

### Claim 16 (depends on 13)

The scaffold of any of claim 13, wherein said agent of interest is incorporated onto said beads though covalent coupling.

### Claim 17 (depends on 13)

The scaffold of any of claim 13, wherein said beads are provided in said hydrogel at a concentration of 103 to 2×1010 beads per cubic centimeter of scaffold volume.

### Claim 18

A method of culturing organized skeletal muscle tissue from precursor muscle cells, comprising cyclically stretching and relaxing said muscle cells on a scaffold in vitro for a time sufficient to produce said organized skeletal muscle tissue, and further comprising:
including agrin at separate and discrete locations in or on said scaffold, said agrin provided in an amount effective to promote the formation of aggregated acetylcholine receptors in said organized skeletal muscle adjacent to one or more of said separate and discrete locations.

### Claim 19 (depends on 18)

The method of claim 18, wherein said step of including agrin is carried out by including beads in or on said scaffold, with said beads comprise said agrin.

### Claim 20 (depends on 19)

The method of claim 19, wherein said beads are microbeads.

### Claim 21 (depends on 19)

The method of any of claim 19, wherein said separate and discrete locations are provided at an approximately 1:1, 1:2, 1:3, 1:4, 1:5, 5:1, 4:1, 3:1, or 2:1 ratio with respect to formed myotubes in said organized skeletal muscle tissue.

### Claim 22 (depends on 18)

The method of any of claim 18, wherein said scaffold further comprises one or more agents selected from: heparin-binding growth-associated molecule (HB-GAM), muscarine, acetylcholine receptor antibodies, carbachol, and nicotine.

### Claim 23

A method of culturing organized skeletal muscle tissue from precursor muscle cells comprising: cyclically stretching and relaxing said muscle cells seeded onto a scaffold in vitro for a time sufficient to produce said organized skeletal muscle tissue,
wherein said scaffold comprises fibrinogen, and
wherein said scaffold comprises a plurality of channels aligned along a first axis.

### Claim 24 (depends on 18)

A multi-layered skeletal muscle tissue produced by the process of claim 18.

### Claim 25 (depends on 24)

The tissue of claim 24, wherein said tissue comprises elongated multi-nucleated muscle fibers.

### Claim 26 (depends on 24)

The tissue of claim 24, wherein said tissue expresses acetylcholine (ACh) receptors.

### Claim 27 (depends on 24)

The tissue of claim 24, wherein said tissue comprises aggregated ACh receptors.

### Claim 28 (depends on 24)

The tissue of claim 24, wherein said tissue comprises aggregated ACh receptors forming a pretzel shape characteristic of motor end plates.

### Claim 29 (depends on 25)

The tissue of claim 25, wherein said tissue comprises aggregated ACh receptors which are at a ratio of between 5:1 and 1:5 with respect to said elongated multi-nucleated muscle fibers.

### Claim 30 (depends on 24)

The tissue of claim 24, wherein said tissue is suturable.

### Claim 31 (depends on 24)

A method of treating a skeletal muscle injury or defect in a subject in need thereof comprising grafting the tissue of claim 24 into said subject in a treatment-effective configuration.

### Claim 32

(canceled)
